Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With None–Small-cell Lung Cancer

Immunotherapy is a mainstay of treatment for nonesmall-cell lung cancer. Serious immune-related adverse events (irAEs) occur; however, their effect on survival is unclear, and no defined risks factors have been elucidated. In the present study, we found no significant effect of irAE on survival in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Dwight H., Wei, Lai, Bertino, Erin M., Edd, Thomas, Villalona-Calero, Miguel A., He, Kai, Shields, Peter G., Carbone, David P., Otterson, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193681/
https://www.ncbi.nlm.nih.gov/pubmed/30197259
http://dx.doi.org/10.1016/j.cllc.2018.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193681/
https://www.ncbi.nlm.nih.gov/pubmed/30197259
http://dx.doi.org/10.1016/j.cllc.2018.08.008

Ejemplares similares